Brain Neuronal CB2 Cannabinoid Receptors in Drug Abuse and Depression: From Mice to Human Subjects
2008

Brain Neuronal CB2 Cannabinoid Receptors in Drug Abuse and Depression

Sample size: 166 publication 10 minutes Evidence: moderate

Author Information

Author(s): Onaivi Emmanuel S., Ishiguro Hiroki, Gong Jian-Ping, Patel Sejal, Meozzi Paul A., Myers Lester, Perchuk Alex, Mora Zoila, Tagliaferro Patricia A., Gardner Eileen, Brusco Alicia, Akinshola B. Emmanuel, Hope Bruce, Lujilde Javier, Inada Toshiya, Iwasaki Shinya, Macharia David, Teasenfitz Lindsey, Arinami Tadao, Uhl George R.

Primary Institution: Department of Biology, William Paterson University, Wayne, New Jersey, United States of America

Hypothesis

Genetic variants of the CB2 gene might be associated with depression in a human population and that alteration in CB2 gene expression may be involved in the effects of abused substances.

Conclusion

The study demonstrates the functional expression of CB2 receptors in the brain, suggesting they may be novel targets for treating depression and substance abuse disorders.

Supporting Evidence

  • A high incidence of the Q63R polymorphism in the CB2 gene was found in Japanese depressed subjects.
  • CB2 receptors are expressed in the brains of naïve mice and are modulated by stressors and drug administration.
  • Mice that developed alcohol preference had reduced CB2 gene expression.
  • Chronic treatment with a CB2 receptor agonist enhanced alcohol consumption in stressed mice.
  • Direct microinjection of CB2 anti-sense oligonucleotide reduced mouse aversions in behavioral tests.
  • Significant association was found between the CB2 Q63R polymorphism and depression.
  • CB2 gene expression was confirmed in different mouse brain areas including striatum, midbrain, and hippocampus.
  • Behavioral effects of CB2 receptor activation and blockade were observed in various tests.

Takeaway

This study found that certain genes related to cannabinoid receptors in the brain might affect depression and how people use drugs.

Methodology

The study involved testing CB2 gene expression in mice and analyzing genetic variants in a human population.

Potential Biases

Potential biases may arise from the selection of participants and the reliance on self-reported data for depression.

Limitations

The study primarily focused on a specific population (Japanese) and may not be generalizable to other ethnicities.

Participant Demographics

166 patients with major depression and 487 age- and gender-matched controls from Japan.

Statistical Information

P-Value

0.007

Confidence Interval

1.09–1.83

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0001640

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication